Literature DB >> 28491168

Serous cystadenocarcinoma of the spleen.

Chung Kuao Chou1, Shih-Cheng Chou2.   

Abstract

The commonly seen primary malignant neoplasms of the spleen are angiosarcoma and lymphoma. We present a case of serous cystadenocarcinoma of the spleen. It was presumed to be originated from dropped nonmalignant ovarian tissue, which was accidentally implanted to the splenic surface during hysterectomy and bilateral salpingooophorectomies for torsion of right fallopian tube 9 and half years ago and transformed into serous cystadenocarcinoma later. Computed tomography demonstrated a multilocular predominantly cystic tumor with internal soft tissue components in the spleen.

Entities:  

Keywords:  CT; Serous cystadenocarcinoma; Spleen

Year:  2017        PMID: 28491168      PMCID: PMC5417741          DOI: 10.1016/j.radcr.2017.01.018

Source DB:  PubMed          Journal:  Radiol Case Rep        ISSN: 1930-0433


Introduction

Primary neoplasms of the spleen include lymphoma, angiosarcoma, hemangioma, lymphangioma, littoral cell angioma, hamartoma, and inflammatory pseudotumor [1]. Other unusual tumors include lipoma, angiomyolipoma, fibroma, fibrosarcoma, leiomyosarcoma, malignant fibrous histiocytoma, and mucinous cystadenocarcinoma [1], [2]. The authors report a serous cystadenocarcinoma solitarily present in the spleen and discuss its probable origin.

Case report

A 65 year-old female consulted the internal medical department with a chief complaint of epigastralgia for several months. She received hysterectomy and bilateral salpingooophorectomies 9 and half years ago due to torsion of right fallopian tube. The gross specimens showed torsion of right fallopian tube with swelling and gangrenous change and congestion of right ovary. Bilateral ovaries and left fallopian tube were of normal outlooking and size. The microscopic examination showed hemorrhagic necrosis of left fallopian tube. It did not reveal any malignancy in the uterus, fallopian tubes, and ovaries. This time, the epigastric pain progressively increased in severity and became constant. An upright abdomen film showed splenomegaly. A subsequent computed tomography examination demonstrated a multilocular cystic tumor, about 16.0 cm in greatest dimension, with irregular internal soft tissue components in the spleen (Figs. 1A and B). The patient was admitted to the surgical ward to receive further evaluation. A percutaneous biopsy revealed clusters of moderately differentiated neoplastic cells bearing hyperchromatic nuclei, prominent nucleoli, and vacuolated cytoplasm and arranged in focal papillary pattern. The mucicarmine stain was positive. Immunohistochemically, the tumor cells were positive for cytokeratin (CK) 7, but not for CK20, CDX2, and thyroid transcription factor (TTF)-1. The results suggested a metastatic adenocarcinoma. The serum levels of cancer antigen (CA) 15-3 and CA 125 were 69.3 U/mL (normal <31.3U/mL) and 2352.8 U/mL (normal <35U/mL), respectively. Those of carcinoembryonic antigen (CEA) and CA 19-9 were within normal range. The following surveys in chest, breast, and upper and lower gastrointestinal tracts did not detect any possible primary malignancy. A surgical intervention was performed to remove the spleen. During operation, the spleen was easily isolated and resected without any adhesion to the adjacent organs. The gross specimen (Fig. 2) revealed a multilocular cystic tumor with internal soft tissue components, necrotic tissue, and hemorrhage. There was no detectable mucin content within the tumor. The microscopic examination (Figs. 3A and B) demonstrated clusters of moderately differentiated neoplastic cells bearing hyperchromatic and pleomorphic nuclei, prominent nucleoli, and eosinophilic cytoplasm, which were arranged in papillary pattern. There were multiple psammoma bodies disseminated in the tumor. No mucin-secreted epithelium was found. Immunohistochemically, these tumor cells were positive for CK-7 (Fig. 3C) and Ber-EP4 but negative for CK-20 (Fig. 3D), CDX2, and TTF-1. These results were consistent with serous cystadenocarcinoma [3]. A positron emission tomography examination 1 month later did not detect any other possible malignancy. Based on these findings, a diagnosis of serous cystadenocarcinoma of the spleen was made. The patient was regularly followed up in outpatient department. One and a half year later, a palpable left neck lymph node was noted. The biopsy showed malignant cells with same immunochemical stains, including positive CK-7, negative TTF-1, CK-20, and CD20 stains, as that of splenic serous cystadenocarcinoma. The result was judged as lymph node metastasis. The patient received local adjuvant radiotherapy of the neck and regular follow-up.
Fig. 1

(A) Postcontrast axial image and (B) postcontrast reformatted coronal image. A multilocular predominantly cystic tumor with relatively smooth tumor wall (arrows) and internal soft tissue components (arrowheads) was seen.

Fig. 2

The gross specimen showed the cystic tumor wall (arrows), internal soft tissue components (arrowheads), and a mixture of blood and necrotic tissue (BN).

Fig. 3

(A) A 40× microscopic picture showed neoplastic cells arranged in a papillary pattern. Multiple psammoma bodies (arrows) were seen. (B) A 400× microscopic picture showed clusters of moderately differentiated neoplastic cells bearing hyperchromatic and pleomorphic nuclei, prominent nucleoli, and eosinophilic cytoplasm. (C) The immunohistochemical stain demonstrated diffuse cytoplasmic CK7 expression. (D) The immunohistochemical stain did not demonstrate CK20 expression.

Discussion

Primary neoplasms of the spleen include lymphoma from lymphoid tissue and hemangioma, lymphangiom, hamartoma, littoral cell angioma , hemangioendothelioma, hemangiopericytoma, and angiosarcoma from vascular element [1]. Primary cystadenocarcinoma of the spleen is extremely rare. All the reported cases were mucinous type [2], [4], [5], [6], [7], [8], [9]. The hypothesized origins of these tumors include (1) ectopic pancreatic tissue; (2) ectopic intestinal tissue; and (3) invaginated mesothelium of the splenic capsule [2], [6]. In contrast to the mucinous type, the current case might represent a different entity. The patient received hysterectomy and bilateral salpingooophorectomies 9 and half years ago due to torsion of right fallopian tube. Neither gross specimens, including normal endometrial thickness and ovarian sizes, nor microscopic examinations revealed any evidence of gynecologic malignancy. This time, she was found to have a multilocular predominantly cystic tumor with internal soft tissue components in the spleen. Immunohistochemically, the neoplastic epithelial cells were positive for CK-7 and negative for CK-20, suggestive of a serous cystadenocarcinoma [3]. A CK7+/CK20− expression was seen in most serous ovarian cystadenocarcinoma [3], [10], [11]. On the other hand, mucinous ovarian carcinoma tends to have an 80% of CK20+ expression [3], [12]. Microscopically, the hyperchromatic and pleomorphic neoplastic cells and psammoma bodies were compatible with serous carcinoma. Combining the gross tumor appearance, immunohistochemical stains, and histomorphological pictures together, serous cystadenocarcinoma is most likely. The remaining issue is whether the tumor was primary or metastatic. Histologically, the splenic parenchyma is composed of lymphoid and vascular tissues. Neither of them has a serous-secreting function. The patient had normal serum CEA and CA 19-9 levels, which indicated lower possibility of intestinal or pancreatic adenocarcinoma. A positive Ber-EP4 immunochemical stain almost excluded a mesothelium-origin malignancy [13]. The presumed tumor origins of mucinous cystadenocarcinoma of the spleen were not applicable in our case. It seemed metastasis would be more likely. However, the patient did not have any previously confirmed or currently detected malignancy after a thorough clinical and imaging survey. Then, the previous operation history suggested a very unusual possibility that minute nonmalignant tissue from an intra-abdominal organ such as ovary, stomach, colon, pancreas, or others might be dropped and accidentally implanted to the splenic surface during the surgery and transformed into cancer later. Generally, simultaneous elevation of serum levels of both CA 125 and CA 15-3, like in this patient, favors an ovarian carcinoma [14]. On the other hand, normal CEA and CA 19-9 levels decrease the likelihood of gastrointestinal or pancreatic origins [15], [16]. Furthermore, CK7+/CK20− and negative CDX2 immunophenotypes nearly completely exclude the possibility of colorectal carcinoma [17]. These results suggest that ovary would be the most probable origin. It has been supposed that an early blood-borne micrometastasis within the spleen may grow into an imaging-detectable metastasis after several years [18]. Solitary splenic metastasis from ovarian serous adenocarcinoma has been reported [19], [20], [21], [22], [23], [24]. Those cases experienced a disease-free period, ranging from 2 to 10 years, from the first diagnosis of ovarian cancer to the detection of splenic metastasis. Most cases had an elevated serum CA 125 level before or at the moment of imaging detection. In contrast, our patient has not been found to have any gynecologic malignancy before. It may be argued that occult cancer cells might be released from the normally appearing ovaries during surgery. However, this possibility would be never ascertained. From the morphologic point of view, the tumor in the present case was a predominantly cystic tumor with relatively smooth wall and internal solid components (Figs. 1 and 2). Thus, the differential diagnoses may exclude most solid tumors and limited to cystic ones [25], [26]. Primary benign cystic tumors, including posttraumatic, postinflammatory, or postinfectious pseudocysts; congenital cysts; lymphangioma; and littoral cell angioma, usually do not have internal solid components. Clinical information is also useful in excluding irregular-marginated cystic lesions, such as immature abscess. Primary malignant tumors with necrosis usually have irregular peripheral margin in contrast to the current case, which still possessed relatively smooth wall. Then, cystic metastasis should be the remaining consideration. The majority of splenic metastasis is originated from breast, lung, colorectum, ovary, stomach, and skin [27]. In our case, all these sites, with the exception of ovary, have been examined by physical inspection, mammography, radiography, endoscopy, and nuclear medicine study. Even so, no malignancy was found. In conclusion, we have reported a serous cystadenocarcinoma of the spleen. The serum levels of various tumor markers, gross tumor appearance, and immunohistochemical expressions and histomorphological findings of microscopic specimens favored serous cystadenocarcinoma originated from ovary. In the absence of any evidence of other primary malignancy after serial endoscopic, radiologic, and nuclear medical imaging surveys, the clinical history elicits a possibility that minute dropped nonmalignant tissue from an intra-abdominal organ such as ovary, colon, stomach, pancreas, or others was implanted to the splenic surface during the process of hysterectomy and salpingooophorectomy and developed into serous cystadenocarcinoma 9 and half years later. Based on the above described biochemical data, that is, elevated CA 125/CA 15-3 and normal CEA/CA 19-9 levels, and immunochemical findings, that is, CK7+/CK20−/CDX2−, ovary would be the most likely origin of the splenic serous cystadenocarcinoma of the current case.
  26 in total

Review 1.  Cystic masses of the spleen: radiologic-pathologic correlation.

Authors:  M Urrutia; P J Mergo; L H Ros; G M Torres; P R Ros
Journal:  Radiographics       Date:  1996-01       Impact factor: 5.333

Review 2.  Solitary splenic lesions.

Authors:  David M Warshauer; H Lee Hall
Journal:  Semin Ultrasound CT MR       Date:  2006-10       Impact factor: 1.875

3.  Solitary metastatic ovarian carcinoma of the spleen: a case report.

Authors:  Y Minagawa; Y Kanamori; H Ishihara; K Morishita; J Kigawa; T Ito; K Maeda; S Saito
Journal:  Asia Oceania J Obstet Gynaecol       Date:  1991-03

4.  A case of splenic low-grade mucinous cystadenocarcinoma resulting in pseudomyxoma peritonei.

Authors:  Chisato Ohe; Noriko Sakaida; Yasuaki Yanagimoto; Hideyoshi Toyokawa; Sohei Satoi; A-Hon Kwon; Chika Tadokoro; Kosho Takasu; Yoshiko Uemura
Journal:  Med Mol Morphol       Date:  2011-01-26       Impact factor: 2.309

5.  Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: comparison with CK20 and correlation with coordinate expression of CK7.

Authors:  Russell Vang; Allen M Gown; Lee-Shu-Fune Wu; Todd S Barry; Darren T Wheeler; Anna Yemelyanova; Jeffrey D Seidman; Brigitte M Ronnett
Journal:  Mod Pathol       Date:  2006-09-15       Impact factor: 7.842

6.  Heterotopic pancreas in the spleen: malignant degeneration to mucinous cystadenocarcinoma.

Authors:  Pasha J Nisar; Abid M Zaitoun; Dileep N Lobo; Brian J Rowlands
Journal:  Eur J Gastroenterol Hepatol       Date:  2002-07       Impact factor: 2.566

7.  Cytokeratin immunostaining in differentiating primary ovarian carcinoma from metastatic colonic adenocarcinoma.

Authors:  T S Loy; R D Calaluce; G L Keeney
Journal:  Mod Pathol       Date:  1996-11       Impact factor: 7.842

8.  Splenic mucinous cystadenocarcinoma arising in heterotopic pancreatic tissue.

Authors:  G Zanetti; L Riccioni; C Gallo; N Salfi; G N Martinelli
Journal:  Tumori       Date:  1998 Sep-Oct

9.  Immunohistochemistry: A diagnostic aid in differentiating primary epithelial ovarian tumors and tumors metastatic to the ovary.

Authors:  Divya Kriplani; Mandakini M Patel
Journal:  South Asian J Cancer       Date:  2013-10

10.  Diagnostic accuracy of Ber-EP4 for metastatic adenocarcinoma in serous effusions: a meta-analysis.

Authors:  Bo Wang; Diandian Li; Xuemei Ou; Qun Yi; Yulin Feng
Journal:  PLoS One       Date:  2014-09-17       Impact factor: 3.240

View more
  2 in total

1.  A unique case of splenic tumor exhibiting a serous carcinoma phenotype.

Authors:  Keisuke Kawashima; Yusuke Kito; Koya Tochii; Masaki Kimura; Taro Takeda; Takafumi Sekino; Tsuneko Ikeda; Tamotsu Takeuchi
Journal:  SAGE Open Med Case Rep       Date:  2021-05-24

2.  Isolated splenic high-grade serous carcinoma: A case report.

Authors:  Ralph Rogers; Sarah Ehmann; William P Tew; Vance Broach
Journal:  Gynecol Oncol Rep       Date:  2021-06-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.